Market Overview:
The global over the counter analgesics market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as rising prevalence of chronic diseases, increasing demand for pain relief medications, and growing awareness about over the counter analgesics. The global over the counter analgesics market is segmented on the basis of type into tablets, capsules, and other types. The tablets segment is expected to account for a major share of the global over the counter analgesics market in 2018 owing to their high demand and widespread use. By application, retail pharmacies accounted for a major share of the global overthecounter analgesics market in 2017 due to their large customer base across all regions.
 Analgesics Industry Outlook.svg)
Product Definition:
Analgesics are medications used to relieve pain. Over the counter (OTC) analgesics are medications that can be purchased without a prescription. OTC analgesics include ibuprofen, aspirin, and acetaminophen. These medications are important because they can be used to treat a variety of different types of pain, including muscle aches, headaches, and toothaches.
Tablet:
The global tablet market is expected to grow at a CAGR of XX% during the forecast period. The growth can be attributed to factors such as increasing geriatric population, rising healthcare costs, and growing awareness regarding OTC analgesics.
According to data published by the United Nations in 2012, it was estimated that there were about 809 million people aged above 60 years across the globe which accounted for 13% of the total world population.
Capsule:
A capsule is a small container made up of gelatin, sugar, and other fillings. It is used to hold drugs or medicine for later use. The most common type of capsule used in OTC analgesics market are soft gelatin capsules containing an analgesic drug such as paracetamol (Acetaminophen) and ibuprofen; however, there are several other types including hard gelatin capsules and liquid-filled capsules among others that are also widely used in the market.
Application Insights:
The retail pharmacies accounted for the largest share of more than 60.0% in 2017. The growing prevalence of pain and increasing awareness about OTC analgesics are factors responsible for high market penetration in this segment. According to a study published by NCBI, it is estimated that around 80% to 90% of the patients who seek medical care at pain clinics have chronic pain (lasting 6 months or longer) and/or acute pain (lasting 7 days or longer). Therefore, based on the aforementioned facts, it can be presumed that most of the population suffers from some form of chronic or acute pains which needs continuous treatment with OTC analgesics so as to get relief from such pains. This trend is expected to expand opportunities for retail pharmacies over the forecast period as they are easily available and affordable products which fulfill various health requirements within a household without any professional help.
Regional Analysis:
Asia Pacific was the largest regional OTC analgesics market in 2017 owing to growing population, rising disposable income and presence of key manufacturers in China. Moreover, increasing number of retail pharmacies due to expansion of distribution network by major players is expected to drive growth over the forecast period. Increasing prevalence of pain and chronic diseases such as arthritis & osteoarthritis is also driving demand for OTC products in this region.
North America held a significant share followed by Europe due their high spending power and availability of advanced treatment options at affordable prices coupled with strong distribution networks operated by leading companies such as Johnson & Johnson Consumer Inc.; Merck KGaA; Pfizer Inc.
Growth Factors:
- Increasing incidence of chronic pain: The global prevalence of chronic pain is estimated to be around 20%. This number is expected to grow as the population ages, making analgesics a necessary part of treatment for many people.
- Rising awareness of over-the-counter analgesics: As people learn more about the benefits and risks of various types of analgesics, they are increasingly choosing OTC medications for relief from minor aches and pains.
- Availability of new products: Pharmaceutical companies are constantly developing new over-the-counter analgesic products in an effort to meet consumer demand for better relief options.
- Growing popularity of natural remedies: A growing number of consumers are turning to herbal or other natural remedies for pain relief instead traditional OTC drugs, often because they perceive these alternatives as being safer or more effective than prescription medications .
Scope Of The Report
Report Attributes
Report Details
Report Title
Over the Counter (OTC) Analgesics Market Research Report
By Type
Tablet, Capsule, Other
By Application
Retail Pharmacies, Hospital Pharmacies, Online Pharmacies
By Companies
Pfizer, Johnson & Johnson, AstraZeneca, Novartis, Sun Pharma, Bayer AG, Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, Reckitt Benckiser Group PLC, Sanofi SA, Takeda Pharmaceutical Company Limited.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
138
Number of Tables & Figures
97
Customization Available
Yes, the report can be customized as per your need.
Global Over the Counter (OTC) Analgesics Market Report Segments:
The global Over the Counter (OTC) Analgesics market is segmented on the basis of:
Types
Tablet, Capsule, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Retail Pharmacies, Hospital Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Johnson & Johnson
- AstraZeneca
- Novartis
- Sun Pharma
- Bayer AG
- Boehringer Ingelheim International GmbH
- GlaxoSmithKline PLC
- Reckitt Benckiser Group PLC
- Sanofi SA
- Takeda Pharmaceutical Company Limited.
 Analgesics Market Overview.svg)
Highlights of The Over the Counter (OTC) Analgesics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet
- Capsule
- Other
- By Application:
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Over the Counter (OTC) Analgesics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Analgesics Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
OTC analgesics are medications that are not typically prescribed by a doctor, but can be purchased over the counter. These medications include ibuprofen and acetaminophen (Tylenol).
Some of the major companies in the over the counter (otc) analgesics market are Pfizer, Johnson & Johnson, AstraZeneca, Novartis, Sun Pharma, Bayer AG, Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, Reckitt Benckiser Group PLC, Sanofi SA, Takeda Pharmaceutical Company Limited..
The over the counter (otc) analgesics market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Over the Counter (OTC) Analgesics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Over the Counter (OTC) Analgesics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Over the Counter (OTC) Analgesics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Over the Counter (OTC) Analgesics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Over the Counter (OTC) Analgesics Market Size & Forecast, 2018-2028
4.5.1 Over the Counter (OTC) Analgesics Market Size and Y-o-Y Growth
4.5.2 Over the Counter (OTC) Analgesics Market Absolute $ Opportunity
Chapter 5 Global Over the Counter (OTC) Analgesics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Over the Counter (OTC) Analgesics Market Size Forecast by Type
5.2.1 Tablet
5.2.2 Capsule
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Over the Counter (OTC) Analgesics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Over the Counter (OTC) Analgesics Market Size Forecast by Applications
6.2.1 Retail Pharmacies
6.2.2 Hospital Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Over the Counter (OTC) Analgesics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Over the Counter (OTC) Analgesics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Over the Counter (OTC) Analgesics Analysis and Forecast
9.1 Introduction
9.2 North America Over the Counter (OTC) Analgesics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Over the Counter (OTC) Analgesics Market Size Forecast by Type
9.6.1 Tablet
9.6.2 Capsule
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Over the Counter (OTC) Analgesics Market Size Forecast by Applications
9.10.1 Retail Pharmacies
9.10.2 Hospital Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Over the Counter (OTC) Analgesics Analysis and Forecast
10.1 Introduction
10.2 Europe Over the Counter (OTC) Analgesics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Over the Counter (OTC) Analgesics Market Size Forecast by Type
10.6.1 Tablet
10.6.2 Capsule
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Over the Counter (OTC) Analgesics Market Size Forecast by Applications
10.10.1 Retail Pharmacies
10.10.2 Hospital Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Over the Counter (OTC) Analgesics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Over the Counter (OTC) Analgesics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Over the Counter (OTC) Analgesics Market Size Forecast by Type
11.6.1 Tablet
11.6.2 Capsule
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Over the Counter (OTC) Analgesics Market Size Forecast by Applications
11.10.1 Retail Pharmacies
11.10.2 Hospital Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Over the Counter (OTC) Analgesics Analysis and Forecast
12.1 Introduction
12.2 Latin America Over the Counter (OTC) Analgesics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Over the Counter (OTC) Analgesics Market Size Forecast by Type
12.6.1 Tablet
12.6.2 Capsule
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Over the Counter (OTC) Analgesics Market Size Forecast by Applications
12.10.1 Retail Pharmacies
12.10.2 Hospital Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Over the Counter (OTC) Analgesics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Over the Counter (OTC) Analgesics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Over the Counter (OTC) Analgesics Market Size Forecast by Type
13.6.1 Tablet
13.6.2 Capsule
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Over the Counter (OTC) Analgesics Market Size Forecast by Applications
13.10.1 Retail Pharmacies
13.10.2 Hospital Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Over the Counter (OTC) Analgesics Market: Competitive Dashboard
14.2 Global Over the Counter (OTC) Analgesics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Johnson & Johnson
14.3.3 AstraZeneca
14.3.4 Novartis
14.3.5 Sun Pharma
14.3.6 Bayer AG
14.3.7 Boehringer Ingelheim International GmbH
14.3.8 GlaxoSmithKline PLC
14.3.9 Reckitt Benckiser Group PLC
14.3.10 Sanofi SA
14.3.11 Takeda Pharmaceutical Company Limited.
